📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 8 points (worsening)
💹 Market Data
Market Cap$40.83B
Shares Outstanding4.43B
FloatN/A
Cash$1.81B
Debt$11.60B
Short InterestN/A
🏛 Institutional Holdings
2 institutional holders · 12.60M shares
#1
Aristotle Capital Management, LLC
12.59M shares
#2
Saranac Partners Ltd
12.4K shares
📉 Short Interest
Short Interest15.27M
Days to Cover2.2
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for HLN
📊 HLN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 HLN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.